SELLAS Life Sciences
159 hedge funds and large institutions have $228M invested in SELLAS Life Sciences in 2026 Q1 according to their latest regulatory filings, with 66 funds opening new positions, 53 increasing their positions, 18 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
42% more funds holding
Funds holding: 112 → 159 (+47)
5.16% more ownership
Funds ownership: 24.89% → 30.05% (+5.2%)
Holders
159
Holding in Top 10
–
Calls
$102M
Puts
$11.3M
Top Buyers
| 1 | +$27.8M | |
| 2 | +$20.8M | |
| 3 | +$5.57M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.74M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.12M |
Top Sellers
| 1 | -$5.5M | |
| 2 | -$3.04M | |
| 3 | -$2.14M | |
| 4 |
CS
Clear Street
New York
|
-$1.89M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$1.58M |
